Entries by ignacioriesgo

7 days in healthcare (September 19th-25th, 2022)

  Summary From the point of view of biomedicine, to review the articles in The Economist on advances in knowledge of the brain, which will have a great impact on the appearance of new drugs and pain therapy. With regard to Global Health, the WHO report of September 21, which places cancers, cardiovascular conditions and […]

7 days in healthcare (September 12th-18th, 2022)

  Summary From the point of view of biomedicine, immunotherapy (in colon cancer) and CAR-T therapies (in lupus) continue to expand their therapeutic possibilities. Advances against infections for resistant bacteria. Will there ever come a time when cancer can be diagnosed by a simple blood test? This possibility does not seem very remote, according to […]

7 days in healthcare (September 5th-11th, 2022)

  Summary From the point of view of Biomedicine, to highlight the work that shows an association between artificial sweeteners and increased cardiovascular risk. Also that air pollution causes lung cancer. As far as Global Health is concerned, apart from the serious humanitarian crises in Pakistan and Somalia, the most promising is the new malaria […]

7 days in healthcare (August 29th-September 4th, 2022)

  Summary From the point of view of Biomedicine, the great impact of the study by scientists from the University of Oviedo, who have studied the genes of a species of jellyfish, which incorporates rejuvenation elements in its life cycle, should be highlighted. With regard to Global Health, historical decline in life expectancy in the […]

7 days in healthcare (August 21st-28th, 2022)

  Summary From the point of view of biomedicine, the very encouraging results of the polypill published by a Spanish group led by Valentin Fuster should be highlighted. The Economist underlines the great future of gene therapies in medicine, with a list of diseases for which there is a therapy or is in advanced study. […]

7 days in healthcare (August 15-21, 2022)

Summary From the point of view of biomedicine, the first drug is prepared using CRISPR (gene editing) technology. Important publication from The Lancet in the largest effort yet to identify risk factors in relation to cancer. Not surprisingly, however, tobacco and alcohol are the biggest risk factors, particularly tobacco. As far as Global Health is […]

7 days in healthcare (August 8th-14th, 2022)

  Summary From the point of view of biomedicine, there seems to be a glimpse of a new drug to prevent the transmission of HIV/AIDS, for which there are problems in obtaining an affordable price. Animal testing is the basis for certain advances in medicine. This can be overcome with certain new discoveries, according to […]

7 days in healthcare (1st-7th August 2022)

    Summary From the point of view of biomedicine, to highlight the use of monoclonal antibodies to combat malaria; also the return to life of cells and tissues in dead pigs, which may be important in transplants; and, the fact that the genomic map of chronic lymphatic leukemia has been completed, which, sooner or […]

7 days in healthcare (25th-31st July, 2022)

  Summary From the point of view of biomedicine, it should be noted that the origin of acute childhood hepatitis has been discovered, it turns out to be due to a co-infection of two viruses, ruling out covid as the cause of this disease. Major advances by a group of Yale scientists in the treatment […]

7 days in healthcare (July 18th-24th, 2022)

  Summary From the point of view of Biomedicine, it is worth highlighting the finding published by “Science” that in covid the continuous appearance of variants is the new normality, but the appearance of a totally new variant cannot be ruled out. We must also highlight the very promising advances published in the treatment of […]